首页> 外文期刊>Chemical and Pharmaceutical Bulletin >A 3D-QSAR Analysis of CDK2 Inhibitors Using FMO Calculations and PLS Regression
【24h】

A 3D-QSAR Analysis of CDK2 Inhibitors Using FMO Calculations and PLS Regression

机译:使用FMO计算和PLS回归的CDK2抑制剂3D-QSAR分析

获取原文
       

摘要

We report a three-dimensional quantitative structure–activity relationship (3D-QSAR) analysis of CDK2 inhibitors using fragment molecular orbital (FMO) calculations and partial least squares (PLS) regression. In our analysis, fragment binding energies of individual amino acids and fragment binding energy of a single ligand in a protein–ligand complex are evaluated by FMO calculations and used as descriptors in PLS regression to estimate biological activities of the ligands. The analysis was applied to the system of CDK2 protein and its inhibitors and the effectiveness of the method was tested. Application of the 3D-QSAR model demonstrated that it offered good predictive ability and was able to predict not only biological activity of ligands but also identify important amino acid residues which could be targeted in order to improve ligand activity.
机译:我们报告了使用碎片分子轨道(FMO)计算和偏最小二乘(PLS)回归分析CDK2抑制剂的三维定量结构-活性关系(3D-QSAR)分析。在我们的分析中,通过FMO计算来评估蛋白质-配体复合物中单个氨基酸的片段结合能和单个配体的片段结合能,并将其用作PLS回归的描述符,以评估配体的生物学活性。该分析应用于CDK2蛋白及其抑制剂的体系,并测试了该方法的有效性。 3D-QSAR模型的应用表明,它具有良好的预测能力,不仅可以预测配体的生物学活性,而且还可以识别重要的氨基酸残基,从而可以提高配体的活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号